Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 10—October 2004
Letter

SARS in Teaching Hospital, Taiwan

On This Page
Article Metrics
11
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: During the global epidemic of severe acute respiratory syndrome (SARS), the illness was transmitted rapidly within hospitals, which created pools of persons who became infected and through whom the disease was spread. Intrahospital transmission amplified regional outbreaks and augmented spread of the illness into the community (13). Healthcare workers, hospital patients, and hospital visitors accounted for 18%–58% of all cases of SARS in the five countries with the largest outbreaks (1,2). The concentration of SARS among hospital staff strained hospital facilities, personnel, and finances.

National Taiwan University Hospital, established more than 100 years ago, is the first teaching hospital and the best resource in Taiwan for managing patients with illnesses that are difficult to treat. The hospital has 2,400 beds and provides primary and tertiary care services in Taipei. Taipei City was among the hardest hit areas by SARS in the world (3). From March 10 to July 23, 2003, the hospital reported 270 patients with SARS, many of whom were severely ill. The hospital treated 158 of the 665 patients with SARS reported in Taiwan, even though it was staffed by 4,450 of the country’s 178,000 healthcare workers. SARS had an impact on this hospital for three likely reasons. First, the hospital identified and treated the first SARS patients in Taiwan (4,5). Second, it provided easy access through the emergency room and outpatient clinics. Febrile persons with a travel history to SARS-affected areas or other risk of SARS exposure came directly to this hospital for care. Third, many hospitals, particularly private facilities, were reluctant to report and admit patients with SARS during the early stage of the epidemic because of financial considerations and fear.

The hospital felt the brunt of the epidemic in Taiwan during early May 2003, which paralleled the severity of the SARS epidemic in Taipei (3,4,6). The maximal number of SARS patients admitted to the hospital within 24 hours was 12 on May 3. The maximal number of SARS patients reported within 24 hours was 15 on May 6; 8 patients were transferred to other hospitals on May 7. However, 18 patients stayed overnight in the emergency room on May 7. Subsequently, SARS developed in 12 emergency room healthcare workers (6,7).

Our preliminary studies showed that the average inpatient cost for patients with SARS was not higher than for patients with pneumonia, after adjustment for age, sex, and length of stay (MF Chen, unpub. data). However, SARS caused financial and operational disruptions in the hospital. During this period, hospital utilization rates decreased. Compared with the previous year’s rates, outpatient and emergency visits fell to 37%, inpatient admissions fell to 29%, and surgical procedures fell to 15%. Bed occupancy decreased from 86% in May 2002 to 38% in May 2003. SARS also imposed physical and psychological concerns on the healthcare workers.

During the later stage of the SARS epidemic, the Taiwan government offered special financial assistance to hospitals and healthcare workers as an incentive to help fight SARS. The country’s National Health Insurance program compensated hospitals for the decrease in revenues, based on the hospital’s reimbursement amount before the SARS epidemic. This measure was effective in motivating other hospitals to accept patients with SARS. The proportion of inpatients with SARS at the hospital dropped from 79.5% during March 10 to April 23, to 46.2% during April 24 to May 1, to 11.6% during May 2 to July 23. This financial assistance program remarkably reduced the impact on the hospital as other hospitals began treating patients with SARS.

Preparations for a medical emergency must address the availability and quality of medical care as well as the implications for public health policy, including political, legal, social, financial, and ethical issues (1). The importance of a sound financial policy cannot be overemphasized. Since the 1980s, healthcare systems have become free market enterprises. Laws and regulations are needed to allow governments to mobilize the resources of all hospitals and compensate them during health crises. Government agencies need to work together with the healthcare system, including health insurance systems and social services, well in advance of epidemic emergencies to maximize limited resources and distribute them equitably.

Democratic societies must preserve human rights (including the right to medical care and freedom from fear), while respecting and protecting the rights and safety of hospitals and healthcare workers. We now face the potential resurgence of SARS, other emerging and reemerging infectious diseases, and the threat of bioterrorism. Careful consideration of the financial issues of hospital management should be an important part of social policy. The emergence of SARS provides a reminder of the potential threat to the entire healthcare system when a new disease suddenly appears. A major lesson from the SARS experience is that government planning and intervention are required.

Top

Acknowledgments

We thank Calvin Kunin for critical review of the manuscript.

This study was supported by a grant from the National Science Council, Republic of China (NSC 92-3112-B-002-043).

Top

Yee-Chun Chen*†, Ming-Fong Chen*†, Shuen-Zen Liu‡, James C. Romeis§, and Yuan-Teh Lee*†Comments to Author 
Author affiliations: *National Taiwan University Hospital, Taipei, Taiwan; †National Taiwan University College of Medicine, Taipei, Taiwan; ‡National Taiwan University College of Management, Taipei, Taiwan; §Saint Louis University, St. Louis, Missouri, USA

Top

References

  1. Centers for Disease Control and Prevention. Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS). [cited 2003 Nov 1]. Available from http://www.cdc.gov/ncidod/sars.htm
  2. World Health Organization. Summary table of SARS cases by country, 1 November 2002–7 August 2003. [cited 2003 Nov 1]. Available from http://www.who.int/csr/sars/country/2003_08_15en/
  3. Lee  ML, Chen  CJ, Su  IJ, Chen  KT, Yeh  CC, King  CC, Severe acute respiratory syndrome—Taiwan, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:4616.PubMedGoogle Scholar
  4. Twu  SJ, Chen  TJ, Chen  CJ, Olsen  SJ, Lee  LT, Fisk  T, Control measures for severe acute respiratory syndrome (SARS) in Taiwan. Emerg Infect Dis. 2003;9:71820.PubMedGoogle Scholar
  5. Chen  YC, Chen  PJ, Chang  SC, Kao  CL, Wang  SH, Wang  LH, Infection control and SARS transmission among healthcare workers, Taiwan. Emerg Infect Dis. 2004;10:8958.PubMedGoogle Scholar
  6. Chen  YC, Huang  LM, Chan  CC, Su  CP, Chang  SC, Chang  YY, SARS in hospital emergency room. Emerg Infect Dis. 2004;10:7828.PubMedGoogle Scholar
  7. Sun  HY, Fang  CT, Wang  JT, Chen  YC, Chang  SC. Treatment of severe acute respiratory syndrome in healthcare workers. Lancet. 2003;362:20256. DOIPubMedGoogle Scholar

Top

Cite This Article

DOI: 10.3201/eid1010.040356

Related Links

Top

Table of Contents – Volume 10, Number 10—October 2004

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Yuan-Teh Lee, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, Taiwan (10016); fax: 886-2-2321-7522

Send To

10000 character(s) remaining.

Top

Page created: April 11, 2011
Page updated: April 11, 2011
Page reviewed: April 11, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external